Victoria Tuckley summarises the 2020 Annual Report. Here, she also highlights how lessons can be learned about communication and robust planning for future emergency situations where the environment is continuously evolving.
Serious Hazards of Transfusion (SHOT) works collaboratively with the Medicines and Healthcare products Regulatory Agency (MHRA) to oversee haemovigilance throughout the UK, collecting and analysing anonymised information relating to serious adverse reactions (SAR) and serious adverse events (SAE) of blood transfusion reported in the UK. SHOT then makes recommendations to improve patient and transfusion safety in the Annual SHOT Report.
The year 2020 was one like no other, and as such the impact on haemovigilance data can be seen in all reporting categories with decreases in the number of reports received in most categories, and a notable increase in the number of febrile, allergic and hypotensive reaction reports. The SHOT 2019 recommendations survey highlighted difficulties in training, incident investigation and haemovigilance culture. Full results can be found on the SHOT website.1
A breakdown of the 2020 Annual SHOT Report (assessing a total of 3214 case reports), is shown in Figure 1.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.